Georgia - Re-Export of Vaccines for Human Use
Since 2014, Georgia Re-Export of Vaccines for Human Use was down by 23.6% year on year. In 2019, the country was ranked number 7 among other countries in Re-Export of Vaccines for Human Use at $363,839.78. Georgia is overtaken by Sri Lanka, which was number 6 with $459,052.07 and is followed by New Zealand at $346,218.92. United States ranked the highest with $21,386,560.62 in 2019, that is a fall of 18% versus 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +106.5% per year, while Trinidad and Tobago recorded the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 363,839.78 |
| 2018 | 108,793.76 |
| 2017 | 446,152.09 |
| 2016 | 1,802.00 |
| 2015 | 660,197.19 |
Download all data from 2010 to 2019
How does Georgia rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 6 |
#6
Sri Lanka
|
459,052.07 | 2019 | +6.0 % | +48.5 % | View data | |
| 7 |
#7
Georgia
|
363,839.78 | 2019 | +234.4 % | -23.6 % | View data | |
| 8 |
#8
New Zealand
|
346,218.91 | 2019 | +227.4 % | +27.2 % | View data | |